Depression is Associated With Sarcopenia Due to Low Muscle Strength: Results From the ELSA-Brasil Study

Carregando...
Imagem de Miniatura
Citações na Scopus
44
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, v.20, n.12, p.1641-1646, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives: To investigate the association of sarcopenia and its defining components with depression in Brazilian middle-aged and older adults. Design: Cross-sectional study. Setting and Participants: This analysis included 5927 participants from the ELSA-Brasil Study second data collection, aged 55 years and older, with complete data for exposure, outcome, and covariates. Measures: Muscle mass was evaluated by bioelectrical impedance analysis and muscle strength by hand-grip strength. Sarcopenia was defined according to the Foundation for the National Institutes of Health (FNIH) criteria. Depression was assessed using the Clinical Interview Scheduled Revised (CIS-R). Information on sociodemographic characteristics, lifestyle, and clinical comorbidities were also obtained. Results: The frequencies of sarcopenia, presarcopenia, low muscle mass, low muscle strength, and low muscle strength without loss of muscle mass was 1.9%, 18.8%, 20.7%, 4.8%, and 2.9%, respectively. After adjustment for sociodemographic characteristics, clinical conditions, and lifestyle factors, depression was associated with sarcopenia (odds ratio [OR] = 2.23, 95% confidence interval [CI] = 1.11-4.48, P = .024) and low muscle strength (OR = 1.94, 95% CI = 1.20-3.15, P = .007), but it was not associated with presarcopenia, low muscle mass, and low muscle strength without loss of muscle mass. Conclusions: Depression is associated with sarcopenia defined by the FNIH criteria mainly because of its association with weakness. Future studies are needed to clarify the temporal relationship between both conditions. (C) 2018 AMDA - The Society for Post-Acute and Long-Term Care Medicine.
Palavras-chave
Sarcopenia, muscle strength, depression, older adult
Referências
  1. Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P284, DOI 10.1007/s12603-013-0413-0
  2. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  3. Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548
  4. Berk M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-74
  5. Brasil Ministerio da Saude, VIG BRAZ 2010 PROT R
  6. Byeon CH, 2016, KOREAN J FAM MED, V37, P37, DOI 10.4082/kjfm.2016.37.1.37
  7. Chang KV, 2017, AGE AGEING, V46, P738, DOI 10.1093/ageing/afx094
  8. Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025
  9. Cho Y, 2015, NUTR RES, V35, P384, DOI 10.1016/j.nutres.2015.04.002
  10. Cooper R, 2015, J GERONTOL A-BIOL, V70, P604, DOI 10.1093/gerona/glu214
  11. Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
  12. Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
  13. Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013
  14. Vasconcelos KSD, 2016, J NUTR HEALTH AGING, V20, P306, DOI 10.1007/s12603-015-0584-y
  15. de Souza VA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176230
  16. Eurelings LSM, 2018, CLIN EPIDEMIOL, V10, P363, DOI 10.2147/CLEP.S150915
  17. Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003
  18. Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013
  19. Hamer M, 2015, INT J OBESITY, V39, P1717, DOI 10.1038/ijo.2015.124
  20. Hsu YH, 2014, GERIATR GERONTOL INT, V14, P102, DOI 10.1111/ggi.12221
  21. Ishii S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162898
  22. Kilavuz A, 2018, ARCH GERONTOL GERIAT, V76, P196, DOI 10.1016/j.archger.2018.03.003
  23. Kim JK, 2014, CLIN NUTR, V33, P64, DOI 10.1016/j.clnu.2013.04.002
  24. Kim NH, 2011, J AM GERIATR SOC, V59, P2062, DOI 10.1111/j.1532-5415.2011.03664.x
  25. Lai JS, 2014, AM J CLIN NUTR, V99, P181, DOI 10.3945/ajcn.113.069880
  26. Lee I, 2018, IRAN J PUBLIC HEALTH, V47, P327
  27. Lee JSW, 2007, GERONTOLOGY, V53, P404, DOI 10.1159/000107355
  28. LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415
  29. Luger TM, 2014, ADDICT BEHAV, V39, P1418, DOI 10.1016/j.addbeh.2014.05.011
  30. Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211
  31. Diz JBM, 2017, GERIATR GERONTOL INT, V17, P5, DOI 10.1111/ggi.12720
  32. McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012
  33. Nunes M. A., 2011, REV HCPA, V31, P487
  34. Pasco JA, 2015, CURR OSTEOPOROS REP, V13, P351, DOI 10.1007/s11914-015-0279-7
  35. Phu S, 2015, J CLIN DENSITOM, V18, P488, DOI 10.1016/j.jocd.2015.04.011
  36. Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002
  37. Roubenoff R, 1997, J GERONTOL A-BIOL, V52, pM129, DOI 10.1093/gerona/52A.3.M129
  38. Sayer AA, 2006, AGE AGEING, V35, P409, DOI 10.1093/ageing/afl024
  39. Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097
  40. Schillerstrom JE, 2008, J GERIATR PSYCH NEUR, V21, P183, DOI 10.1177/0891988708320971
  41. Schmidt MI, 2015, INT J EPIDEMIOL, V44, P68, DOI 10.1093/ije/dyu027
  42. Steffl M, 2015, PHYSIOL RES, V64, P419
  43. Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010
  44. Sugimoto T, 2016, CURR ALZHEIMER RES, V13, P718, DOI 10.2174/1567205013666160211124828
  45. Szlejf C, 2018, RES REP MED, V1, P105
  46. Wegner M, 2014, CNS NEUROL DISORD-DR, V13, P1002, DOI 10.2174/1871527313666140612102841
  47. Zeng YL, 2018, J AM MED DIR ASSOC, V19, P690, DOI 10.1016/j.jamda.2018.04.015